PALYNZIQ Trademark

Trademark Overview

On Wednesday, July 5, 2017, a trademark application was filed for PALYNZIQ with the United States Patent and Trademark Office. The USPTO has given the PALYNZIQ trademark a serial number of 87516947. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 8, 2021. This trademark is owned by Biomarin Pharmaceutical Inc.. The PALYNZIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy
palynziq

General Information

Serial Number87516947
Word MarkPALYNZIQ
Filing DateWednesday, July 5, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 7, 2017

Trademark Statements

Indication of Colors claimedThe color(s) navy blue and light green is/are claimed as a feature of the mark.
Description of MarkThe mark consists of an upper-case letter of "P" and the lower-case letters of "alyniq" in navy blue color; the lower-case letter of "z" which has a top and a bottom horizontal lines in navy blue color, with a middle line in light green color.
Goods and ServicesPharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 12, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiomarin Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Monday, February 8, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 8, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 9, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, December 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 12, 2020EXTENSION 5 GRANTED
Monday, June 29, 2020EXTENSION 5 FILED
Monday, June 29, 2020TEAS EXTENSION RECEIVED
Wednesday, December 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2019EXTENSION 4 GRANTED
Monday, December 2, 2019EXTENSION 4 FILED
Monday, December 2, 2019TEAS EXTENSION RECEIVED
Monday, June 17, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2019EXTENSION 3 GRANTED
Monday, June 17, 2019EXTENSION 3 FILED
Monday, June 17, 2019TEAS EXTENSION RECEIVED
Tuesday, April 30, 2019ASSIGNED TO EXAMINER
Wednesday, January 2, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 2, 2019EXTENSION 2 GRANTED
Wednesday, January 2, 2019EXTENSION 2 FILED
Wednesday, January 2, 2019TEAS EXTENSION RECEIVED
Thursday, August 30, 2018CORRECTED NOA E-MAILED
Monday, August 27, 2018DIVISIONAL PROCESSING COMPLETE
Thursday, July 26, 2018DIVISIONAL REQUEST RECEIVED
Tuesday, August 14, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 26, 2018TEAS REQUEST TO DIVIDE RECEIVED
Saturday, June 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 28, 2018EXTENSION 1 GRANTED
Thursday, June 28, 2018EXTENSION 1 FILED
Thursday, June 28, 2018TEAS EXTENSION RECEIVED
Thursday, June 28, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 2, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 28, 2017ASSIGNED TO EXAMINER
Wednesday, July 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 8, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

palynziq pharmaceutical preparations enzyme therapy disorders genetic treatment diseases